These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 736430)

  • 41. Topical pimecrolimus: a new horizon for vitiligo treatment?
    Sendur N; Karaman G; Saniç N; Savk E
    J Dermatolog Treat; 2006; 17(6):338-42. PubMed ID: 17853306
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy, predictors of response, and long-term follow-up in patients with vitiligo treated with narrowband UVB phototherapy.
    Nicolaidou E; Antoniou C; Stratigos AJ; Stefanaki C; Katsambas AD
    J Am Acad Dermatol; 2007 Feb; 56(2):274-8. PubMed ID: 17224369
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Topically administered fluorouracil in vitiligo.
    Tsuji T; Hamada T
    Arch Dermatol; 1983 Sep; 119(9):722-7. PubMed ID: 6614958
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Experience in the use of a psoberan preparation in patients with vitiligo and alopecia].
    Braĭtsev AV
    Vestn Dermatol Venerol; 1975 Sep; (9):53-5. PubMed ID: 1231363
    [No Abstract]   [Full Text] [Related]  

  • 45. Pimecrolimus cream in repigmentation of vitiligo.
    Seirafi H; Farnaghi F; Firooz A; Vasheghani-Farahani A; Alirezaie NS; Dowlati Y
    Dermatology; 2007; 214(3):253-9. PubMed ID: 17377388
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Narrow-band UVB311 nm vs. broad-band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo.
    Hartmann A; Lurz C; Hamm H; Bröcker EB; Hofmann UB
    Int J Dermatol; 2005 Sep; 44(9):736-42. PubMed ID: 16135141
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Double-blind placebo-controlled study of autologous transplanted epidermal cell suspensions for repigmenting vitiligo.
    van Geel N; Ongenae K; De Mil M; Haeghen YV; Vervaet C; Naeyaert JM
    Arch Dermatol; 2004 Oct; 140(10):1203-8. PubMed ID: 15492182
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Repigmentation of vitiligo with punch grafting and narrow-band UV-B (311 nm)--a prospective study.
    Lahiri K; Malakar S; Sarma N; Banerjee U
    Int J Dermatol; 2006 Jun; 45(6):649-55. PubMed ID: 16796620
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of safety and efficacy of topical prostaglandin E2 in treatment of vitiligo.
    Kapoor R; Phiske MM; Jerajani HR
    Br J Dermatol; 2009 Apr; 160(4):861-3. PubMed ID: 19014395
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Topical immunomodulators are effective for treatment of vitiligo.
    Choi CW; Chang SE; Bak H; Choi JH; Park HS; Huh CH; Kim CW; Kim SE; Mun SK; Kim BJ; Kim MN
    J Dermatol; 2008 Aug; 35(8):503-7. PubMed ID: 18789070
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High-dose prednisolone and psoralen ultraviolet A combination therapy in 36 patients with vitiligo.
    Lee Y; Seo YJ; Lee JH; Park JK
    Clin Exp Dermatol; 2007 Sep; 32(5):499-501. PubMed ID: 17608760
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical study of a new preparation of 8-methoxypsoralen in photochemotherapy.
    el-Mofty AM; el-Sawalhy H; el-Mofty M
    Int J Dermatol; 1994 Aug; 33(8):588-92. PubMed ID: 7960360
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oral psoralen with UV-A therapy releases circulating growth factor(s) that stimulates cell proliferation.
    Abdel-Naser MB; Hann SK; Bystryn JC
    Arch Dermatol; 1997 Dec; 133(12):1530-3. PubMed ID: 9420537
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The efficacy of excimer laser (308 nm) for vitiligo at different body sites.
    Hofer A; Hassan AS; Legat FJ; Kerl H; Wolf P
    J Eur Acad Dermatol Venereol; 2006 May; 20(5):558-64. PubMed ID: 16684284
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial.
    Esfandiarpour I; Ekhlasi A; Farajzadeh S; Shamsadini S
    J Dermatolog Treat; 2009; 20(1):14-8. PubMed ID: 18608735
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Response of vitiligo to narrowband ultraviolet B and oral antioxidants.
    Elgoweini M; Nour El Din N
    J Clin Pharmacol; 2009 Jul; 49(7):852-5. PubMed ID: 19553407
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oral trimethylpsoralen in the treatment of vitiligo.
    Theodoridis A; Tsambaos D; Sivenas C; Capetanakis J
    Acta Derm Venereol; 1976; 56(3):253-6. PubMed ID: 59512
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Randomized, double-blind clinical trial to evaluate the efficacy of topical tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligo.
    Rodríguez-Martín M; García Bustínduy M; Sáez Rodríguez M; Noda Cabrera A
    Br J Dermatol; 2009 Feb; 160(2):409-14. PubMed ID: 19016706
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Therapeutic evaluation of UVB-targeted phototherapy in vitiligo that affects less than 10% of the body surface area.
    Welsh O; Herz-Ruelas ME; Gómez M; Ocampo-Candiani J
    Int J Dermatol; 2009 May; 48(5):529-34. PubMed ID: 19416388
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PUVA-induced repigmentation of vitiligo: a histochemical (split-DOPA) and ultrastructural study.
    Ortonne JP; MacDonald DM; Micoud A; Thivolet J
    Br J Dermatol; 1979 Jul; 101(1):1-12. PubMed ID: 113025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.